Kindred Biosciences (KIN) Tops Q1 EPS by 7c

Kindred Biosciences (NASDAQ: KIN) reported Q1 EPS of ($0.34), $0.07 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Jernigan Capital (JCAP) Tops Q2 EPS by 5c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance